USPTO issued Patent Grant US12588910B1 on March 31, 2026, to Vahaticor, Inc. for a vascular flow restriction device system and method. The patent (Application No. 17982912, filed November 8, 2022) covers deployment of flow restriction devices in patient vasculature with recapture and repositioning capabilities after partial or full deployment. The technology enables confirmation of device placement through pressure drop measurements across the deployed device in the coronary sinus before permanent implantation.

This patent grant grants Vahaticor exclusive intellectual property rights to the claimed vascular flow restriction technology in the United States. Competitors developing similar devices should review the patent claims to assess potential infringement risks. Medical device companies engaged in cardiovascular flow restriction technology may need to evaluate whether their products fall within the scope of the single patent claim.